Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10691795 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11CETPALDH1A1L3MBTL1 | |
| SCHEMBL9469790 | 0.91 | CYP4F2 (0.37) | CYP4F2CYP4A11ALDH1A1L3MBTL1MAPT | |
| SCHEMBL9469793 | 0.91 | CYP4F2 (0.37) | CYP4F2CYP4A11ALDH1A1L3MBTL1MAPT | |
| SCHEMBL27542500 | 0.82 | CYP4F2 (0.42) | CYP4F2CYP4A11CETP | |
| Hydrochloric Acid SCHEMBL27539970 | 0.81 | CYP4F2 (0.41) | CYP4F2CYP4A11CETP | |
| SCHEMBL5271625 | 0.78 | CYP4F2 (0.58) | CYP4F2CYP4A11CETPALDH1A1NPSR1 | |
| SCHEMBL9469538 | 0.76 | CYP4F2 (0.38) | CYP4F2CYP4A11ALDH1A1NPSR1MAPT | |
| SCHEMBL9469539 | 0.76 | CYP4F2 (0.38) | CYP4F2CYP4A11ALDH1A1NPSR1MAPT | |
| SCHEMBL13827636 | 0.74 | CYP4F2 (0.56) | CYP4F2CYP4A11CETPALDH1A1L3MBTL1 | |
| SCHEMBL9956623 | 0.73 | RAB9A (0.38) | ALDH1A1NPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0274234-A2 | Spiro-subsituted glutaramide diuretic agents | Pfizer Limited (GB) | 1988-07-13 | — | — | EP | disclosed |